Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25468678 | 0.74 | — | — | |
| SCHEMBL18320214 | 0.73 | ALDH1A1 (0.47) | ALDH1A1MAPK1 | |
| SCHEMBL28738454 | 0.73 | ALDH1A1 (0.56) | ALDH1A1MAPK1 | |
| SCHEMBL13217085 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL28847024 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL404890 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL11662504 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL1529256 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL30356753 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 | |
| SCHEMBL28997946 | 0.71 | ALDH1A1 (0.46) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11742518-B2 | Electrolyte, and electrochemical device and electronic device using the same | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-08-29 | — | — | US | disclosed |
| US-20230155173-A1 | ELECTROLYTE AND ELECTROCHEMICAL DEVICE USING THE SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-05-18 | — | — | US | disclosed |
| US-20210408600-A1 | ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE USING THE SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2021-12-30 | — | — | US | disclosed |
| US-10734677-B2 | Substituted imidazole and benzimidazole lithium salts | ROBERT BOSCH GMBH (DE) | 2020-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10734677-B2 | Substituted imidazole and benzimidazole lithium salts | KCNJ11, KCNJ1, KCNJ8 | ALDH1A1 1039/4885MAPK1 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.